Carlo
PeopleProgramsSpecialtiesInstitutionsPricing
Sign inJoin waitlistJoin the waitlist
Carlo

the ai that helps you match

Part of the Carlo family
© 2026 Carlo Finance, Inc.
PeopleProgramsSpecialtiesInstitutionsPricingMethodologyPrivacyTerms
Back to overview

Ohio State University Pediatric Pulmonology

Fellowship · Columbus, OH

Sponsored by Nationwide Children's Hospital · Director Stephen Kirkby

Research

Works by its people
652
Authors
44
First-author works
185
Citations
21,734
20112026

Topics

  • Cystic Fibrosis Research Advances 149
  • Transplantation: Methods and Outcomes 57
  • Asthma and respiratory diseases 47
  • Obstructive Sleep Apnea Research 32
  • Neonatal Respiratory Health Research 24
  • Neurogenetic and Muscular Disorders Research 19
  • Hemoglobinopathies and Related Disorders 14
  • Tracheal and airway disorders 13
  • Congenital Diaphragmatic Hernia Studies 11
  • Innovations in Medical Education 11
  • Respiratory Support and Mechanisms 9
  • Diversity and Career in Medicine 8

Most cited

  1. Five-Year Extension Results of the Phase 1 START Trial of Onasemnogene Abeparvovec in Spinal Muscular Atrophy.

    JAMA neurology · 2021 · 231 citations · Richard Shell

  2. Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double-blind, placebo-controlled phase 1/2 clinical study.

    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2023 · 116 citations · Karen McCoy

  3. Impact of elexacaftor-tezacaftor-ivacaftor on bacterial colonization and inflammatory responses in cystic fibrosis.

    Pediatric pulmonology · 2023 · 76 citations · Shahid Sheikh, Courtney Gelpi, Karen McCoy

  4. Nutritional considerations for a new era: A CF foundation position paper.

    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2023 · 61 citations · Alpa Patel

  5. Long-term safety and functional outcomes of delandistrogene moxeparvovec gene therapy in patients with Duchenne muscular dystrophy: A phase 1/2a nonrandomized trial.

    Muscle & nerve · 2024 · 69 citations · Richard Shell

  6. Real-world disparities and ethical considerations with access to CFTR modulator drugs: Mind the gap!

    Frontiers in pharmacology · 2023 · 61 citations · Grace R. Paul

  7. Cystic Fibrosis Foundation Evidence-Based Guideline for the Management of CRMS/CFSPID.

    Pediatrics · 2024 · 28 citations · Michael Smiley

  8. Cystic fibrosis macrophage function and clinical outcomes after elexacaftor/tezacaftor/ivacaftor.

    The European respiratory journal · 2023 · 51 citations · Benjamin Wisniewski, Karen McCoy